| Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323 (NCT00484536) | UCB Pharma | 2007-05-01 |
| Study of Fampridine-SR Tablets in Multiple Sclerosis Patients (NCT00483652) | Acorda Therapeutics | 2007-05-01 |
| Firategrast (SB683699) Surface Area Study in Multiple Sclerosis Patients (NCT00548769) | GlaxoSmithKline | 2007-04-21 |
| Modulation of Plasmacytoid Dendritic Cell Function in Multiple Sclerosis (NCT00468182) | Rutgers, The State University of New Jersey | 2007-04-01 |
| Visual Impairment, Oscillopsia and Multiple Sclerosis (NCT00498199) | Hospices Civils de Lyon | 2007-04-01 |
| Phase II Study of Teriflunomide as Adjunctive Therapy to Glatiramer Acetate in Subjects With Multiple Sclerosis (NCT00475865) | Sanofi | 2007-04-01 |
| Constraint-Induced (CI) Movement Therapy for Progressive Multiple Sclerosis (MS) (NCT00695084) | National Multiple Sclerosis Society | 2007-03-01 |
| Avonex 15 Year Long Term Follow-up Study (NCT00525343) | Biogen | 2007-03-01 |
| Brain Peripheral Benzodiazepine Receptors in Patients With Multiple Sclerosis (NCT00432900) | National Institute of Neurological Disorders and Stroke (NINDS) | 2007-02-05 |
| Correlation Between Cognitive Functions and MRI in Multiple Sclerosis (NCT00423111) | Sheba Medical Center | 2007-02-01 |
| A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone (NCT00501696) | University of California, San Francisco | 2007-02-01 |
| Study of Darifenacin in Patients Suffering From Multiple Sclerosis and Neurogenic Detrusor Overactivity (NCT00845338) | Bayer | 2007-02-01 |
| The Effect of Levetiracetam (Keppra) on the Treatment of Tremor in Multiple Sclerosis (NCT00430599) | Newcastle-upon-Tyne Hospitals NHS Trust | 2007-02-01 |
| Validation of an Obstacle Course Used in Patients With Muscle Tightness (NCT00776048) | Kessler Foundation | 2007-01-01 |
| Levetiracetam in Central Pain in Multiple Sclerosis(MS) (NCT00423527) | Odense University Hospital | 2007-01-01 |
| A Study to Test the Use of Duloxetine for Pain in MS (NCT00457730) | Brown, Theodore R., M.D., MPH | 2007-01-01 |
| Rebif Compliance Support Program - Assessing Needs in Multiple Sclerosis (NCT01080573) | Merck KGaA, Darmstadt, Germany | 2007-01-01 |
| Trial of Analgesia With Lidocaine or Extended-release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis (NCT00414453) | University of Rochester | 2007-01-01 |
| Clinical Applications of Advanced Ophthalmic Imaging (NCT03135327) | University of Miami | 2007-01-01 |
| TYSABRI Global Observational Program in Safety (NCT00477113) | Biogen | 2007-01-01 |
| Effects of Vestibular Rehabilitation on MS-related Fatigue: a Randomized Control Trial (NCT01216137) | University of Colorado, Denver | 2007-01-01 |
| Pregnancy Exposure Registry for Tysabri® (NCT00472992) | Biogen | 2007-01-01 |
| Study Of SB-683699 Compared To Placebo In Subjects With Relapsing-Remitting Multiple Sclerosis (MS) (NCT00395317) | GlaxoSmithKline | 2006-12-01 |
| A Phase 2 Study of Cladribine Add-on to Interferon-beta (IFN-beta) Therapy in Multiple Sclerosis (MS) Subjects With Active Disease (ONWARD) (NCT00436826) | EMD Serono Research & Development Institute, Inc. | 2006-11-30 |
| REbif FLEXible Dosing in Early Multiple Sclerosis (MS) (NCT00404352) | Merck KGaA, Darmstadt, Germany | 2006-11-01 |
| Multiple Sclerosis and Heavy Progressive Resistance Training (NCT00381576) | University of Aarhus | 2006-11-01 |
| Use of Two Deep Brain Stimulation (DBS) Electrodes to Treat Post-Traumatic Tremor (NCT00954421) | University of Florida | 2006-11-01 |
| Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250µg in Patients of Chinese Origin With Multiple Sclerosis (NCT00370071) | Bayer | 2006-11-01 |
| A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis (NCT00529581) | Cognition Pharmaceuticals, LLC | 2006-11-01 |
| Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis (NCT00393588) | National Institute of Neurological Disorders and Stroke (NINDS) | 2006-10-26 |
| Whole Body Vibration Therapy in Participants With MS Related Balance Deficits (NCT00510523) | Logan College of Chiropractic | 2006-10-01 |
| Functional and Physiological Responses to Lokomat Therapy (Pilot Study) (NCT00883142) | US Department of Veterans Affairs | 2006-10-01 |
| Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis (NCT00803049) | Sanofi | 2006-10-01 |
| Mesenchymal Stem Cells for the Treatment of MS (NCT00781872) | Hadassah Medical Organization | 2006-10-01 |
| Natalizumab High Titer Immunogenicity and Safety (NCT00516893) | Biogen | 2006-10-01 |
| Simvastatin Treatment of Patients With Acute Optic Neuritis (NCT00261326) | Glostrup University Hospital, Copenhagen | 2006-09-01 |
| Sativex Versus Placebo When Added to Existing Treatment for Central Neuropathic Pain in MS (NCT00391079) | GW Pharmaceuticals Ltd | 2006-09-01 |
| Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Multiple Sclerosis (NCT00381264) | NEMA Research, Inc. | 2006-09-01 |
| TYGRIS - ROW: TYSABRI Global Observational Program in Safety - Rest of World (NCT00483847) | Biogen | 2006-09-01 |
| FolateScan in Autoimmune Disease (NCT00588393) | Mayo Clinic | 2006-09-01 |
| Physical Activity and Fatigue in Early Multiple Sclerosis (MS) (NCT00882453) | Bayer | 2006-08-01 |
| Combination Therapy Using Cellcept and Rebif in RRMS (NCT00618527) | Aaron Boster | 2006-08-01 |
| Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy (NCT00336557) | Teva Branded Pharmaceutical Products R&D, Inc. | 2006-07-01 |
| Memantine for Spasticity in MS Patients (NCT00638027) | University of Rochester | 2006-07-01 |
| Locomotor Training in Persons With Multiple Sclerosis (NCT00607126) | University of California, Los Angeles | 2006-07-01 |
| Cognitive-behavior Therapy for MS-Related Chronic Pain (NCT00323271) | US Department of Veterans Affairs | 2006-07-01 |
| A Comparison of an Implanted Neuroprosthesis With Sensory Training for Improving Airway Protection in Chronic Dysphagia (NCT00376506) | National Institute of Neurological Disorders and Stroke (NINDS) | 2006-07-01 |
| Neuroprotection With Riluzole Patients With Early Multiple Sclerosis (NCT00501943) | University of California, San Francisco | 2006-07-01 |
| Safety Trial of High Dose Oral Vitamin D3 With Calcium in Multiple Sclerosis (NCT00644904) | University of Toronto | 2006-07-01 |
| Climate Influence on Physiotherapy in Multiple Sclerosis (NCT01057719) | Haukeland University Hospital | 2006-06-01 |
| Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial (NCT00648908) | Acorda Therapeutics | 2006-06-01 |
| Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis (NCT00355134) | Novartis | 2006-06-01 |
| Whole Body Vibration Therapy in a Participant With Multiple Sclerosis Related Balance Deficits - A Case Study (NCT00343590) | Logan College of Chiropractic | 2006-06-01 |
| Fatigue in Multiple Sclerosis: Evaluated With 3 MRI and Transcranial Magnetic Stimulation (NCT00342381) | University of Aarhus | 2006-06-01 |
| Biobank For MS And Other Demyelinating Diseases (NCT00445367) | Accelerated Cure Project for Multiple Sclerosis | 2006-05-01 |
| Gait Evaluation in Multiple Sclerosis Patients Treated With Glatiramer Acetate (NCT00331747) | Sheba Medical Center | 2006-05-01 |
| Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase (NCT00340834) | Novartis | 2006-05-01 |
| Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis (NCT00321568) | National Institute of Neurological Disorders and Stroke (NINDS) | 2006-05-01 |
| Safety and Efficacy of Cellcept and Avonex as Combination Treatment in Multiple Sclerosis (NCT00324506) | University of Texas Southwestern Medical Center | 2006-05-01 |
| Treadmill Training in Chronic MS: Efficacy and Cost-effectiveness (NCT00334100) | US Department of Veterans Affairs | 2006-04-01 |
| Measuring the Balance Improvement on Multiple Sclerosis Patients After a Short Training Period With an APOS (All Phase Of Step Cycle) Kit (NCT00338637) | Sheba Medical Center | 2006-04-01 |
| Betaseron Pregnancy Registry (NCT00317564) | Syneos Health | 2006-04-01 |
| Gene Expression Profiles in Multiple Sclerosis (MS) (NCT00704834) | University of California, Davis | 2006-03-01 |
| Neuropathic Pain Assessment Comparing Pregabalin and Paroxetine in Management of MS-induced Neuropathic Pain (NCT00291148) | University of Manitoba | 2006-03-01 |
| Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis (NCT00344253) | Heidelberg University | 2006-03-01 |
| Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis (NCT00492765) | Biogen | 2006-02-01 |
| A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® Alone (NCT00240006) | Teva Neuroscience, Inc. | 2006-01-01 |
| Cranberry for Prevention of Urinary Tract Infections in Multiple Sclerosis Patients (NCT00280592) | Rennes University Hospital | 2006-01-01 |
| A Serologic Study to Correlate Beta-IFN NAb Titers to Beta-IFN Induced Biomarker Response in Patients With Multiple Sclerosis (NCT00288990) | Biogen | 2006-01-01 |
| Characteristic Study on Chinese Patients With Multiple Sclerosis (NCT00818103) | Sun Yat-sen University | 2006-01-01 |
| A Study of the Pharmacokinetics and Immunologic Effects of Lipoic Acid in Multiple Sclerosis (NCT00676156) | Oregon Health and Science University | 2005-12-01 |
| Stem Cell Therapy for Patients With Multiple Sclerosis Failing Alternate Approved Therapy- A Randomized Study (NCT00273364) | Northwestern University | 2005-11-16 |
| Interferon ß-1b Treatment by Cyclical Administration (NCT00270816) | S. Andrea Hospital | 2005-11-01 |
| Evaluation of Brain Atrophy in CIS Patients on Avonex (NCT01592474) | University at Buffalo | 2005-10-01 |
| Health Behavior Change in Chronic Disease Management (NCT00118547) | US Department of Veterans Affairs | 2005-09-01 |
| American Ginseng Treatment for Multiple Sclerosis Related Fatigue (NCT00754832) | Oregon Health and Science University | 2005-09-01 |
| Infections and Autoimmunity: Autobodies Screening in Multiple Sclerosis (NCT00230204) | Sheba Medical Center | 2005-09-01 |
| Study on Cognitive Disorders of Multiple Sclerosis (NCT01074619) | University Hospital, Caen | 2005-09-01 |
| Cognitive Effects of Immunomodulatory Drugs in MS (NCT00229502) | Sharon Lynch, MD | 2005-09-01 |
| A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone® (NCT00239993) | Teva Neuroscience, Inc. | 2005-08-01 |
| Patient Satisfaction Study of Single-Use Autoinjector for the Delivery of Pre-Filled Avonex Syringe (NCT00915577) | Biogen | 2005-08-01 |
| Use of Cannabinoids in Patients With Multiple Sclerosis (NCT00202423) | S. Andrea Hospital | 2005-07-01 |
| Fish Oil for the Treatment of Depression in Patients With Multiple Sclerosis (NCT00122954) | Oregon Health and Science University | 2005-07-01 |
| POPART'MUS: Prevention of Post Partum Relapses With Progestin and Estradiol in Multiple Sclerosis (NCT00127075) | Hospices Civils de Lyon | 2005-06-01 |
| Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia (NCT00202397) | S. Andrea Hospital | 2005-06-01 |
| Effect of Interferon Beta-1a (Avonex®) on Changes of Non-conventional MRI Measures in Patients With MS (NCT00463710) | State University of New York at Buffalo | 2005-06-01 |
| Masitinib in Primary Progressive Multiple Sclerosis or Relapse-free Secondary Progressive Multiple Sclerosis (NCT01450488) | AB Science | 2005-06-01 |
| Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-Beta-1b (NCT00942591) | Insel Gruppe AG, University Hospital Bern | 2005-05-01 |
| Stress Management for Patients With Multiple Sclerosis (NCT00147446) | Northwestern University | 2005-05-01 |
| Study of the Safety and Efficacy of MLN1202 in Patients in Multiple Sclerosis (NCT01199640) | Millennium Pharmaceuticals, Inc. | 2005-05-01 |
| Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis (NCT00094172) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-05-01 |
| Study of Oral Fampridine-SR in Multiple Sclerosis (NCT00127530) | Acorda Therapeutics | 2005-05-01 |
| Promoting Physical Activity for Persons With Multiple Sclerosis (NCT00513448) | University of Minnesota | 2005-04-01 |
| Ambulation Study in Multiple Sclerosis (NCT00424359) | Brown, Theodore R., M.D., MPH | 2005-04-01 |
| Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis (NCT00109161) | PDL BioPharma, Inc. | 2005-04-01 |
| A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis (NCT01599234) | Jazz Pharmaceuticals | 2005-03-01 |
| Efficacy of 3,4-DAP in Fatigue Associated With Multiple Sclerosis (NCT00190268) | Assistance Publique - Hôpitaux de Paris | 2005-02-01 |
| Improving New Learning and Memory in Multiple Sclerosis (NCT00166283) | Kessler Foundation | 2005-02-01 |
| A Multicenter, Open-label Randomized Crossover Trial to Assess Subject Preference for Kemstro™ Compared to Conventional Baclofen Tablets in Subjects With Stable Multiple Sclerosis (NCT00139789) | UCB Pharma | 2005-01-01 |
| Rebif New Formulation (RNF) in Relapsing Forms of Multiple Sclerosis (NCT00110396) | EMD Serono | 2005-01-01 |